|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,047.00 GBX | +1.95% |
|
+2.15% | +2.25% |
| Capitalization | 1.76B 1.53B 1.44B 1.31B 2.42B 152B 2.72B 17.03B 6.52B 69.82B 6.6B 6.46B 257B | P/E ratio 2025 * |
13.1x | P/E ratio 2026 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.69B 1.47B 1.38B 1.25B 2.32B 146B 2.62B 16.35B 6.26B 67.07B 6.34B 6.21B 247B | EV / Sales 2025 * |
1.64x | EV / Sales 2026 * | 1.38x |
| Free-Float |
96.11% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Indivior PLC
More recommendations
More press releases
More news
| 1 day | +1.95% | ||
| 1 week | +2.15% | ||
| Current month | +10.85% | ||
| 1 month | +23.76% | ||
| 3 months | +38.04% | ||
| 6 months | +14.49% | ||
| Current year | +2.25% |
| 1 week | 1,008 |  | 1,070 |
| 1 month | 817 | | 1,070 |
| Current year | 598.5 | | 1,070 |
| 1 year | 554.5 | | 1,340 |
| 3 years | 554.5 | | 2,020 |
| 5 years | 335 | | 2,020 |
| 10 years | 104.9 | | 2,523 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Ciaffoni
CEO | Chief Executive Officer | 54 | - |
Ryan Preblick
DFI | Director of Finance/CFO | 49 | 2020-06-28 |
Vishal Kalia
COO | Chief Operating Officer | 44 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Juliet Thompson
BRD | Director/Board Member | 58 | 2021-03-23 |
Mark Stejbach
BRD | Director/Board Member | 62 | 2021-03-23 |
Barbara Ryan
BRD | Director/Board Member | 65 | 2022-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.95% | +2.15% | -18.52% | -25.85% | 1.76B | ||
| +1.24% | -3.92% | -33.79% | -30.06% | 55.29B | ||
| +0.12% | -0.30% | -7.73% | -15.12% | 8.91B | ||
| -0.64% | -2.17% | +3.83% | +19.64% | 6.51B | ||
| +3.07% | -2.16% | +33.42% | +110.02% | 5.65B | ||
| +2.99% | +2.88% | +20.96% | +37.83% | 5.31B | ||
| -1.24% | -13.37% | +55.19% | -6.97% | 3.22B | ||
| -2.06% | +0.78% | +20.45% | +19.47% | 2.02B | ||
| -0.10% | -3.42% | -0.57% | +14.44% | 1.95B | ||
| -0.95% | -2.04% | -58.69% | -17.34% | 1.72B | ||
| Average | +0.44% | -2.23% | +1.45% | +10.61% | 9.23B | |
| Weighted average by Cap. | +1.00% | -3.05% | -16.55% | -9.49% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.03B 895M 843M 766M 1.42B 89.36B 1.6B 9.98B 3.82B 40.94B 3.87B 3.79B 150B | 1.06B 921M 868M 788M 1.46B 91.99B 1.64B 10.28B 3.93B 42.14B 3.99B 3.9B 155B |
| Net income | 140M 122M 115M 104M 193M 12.17B 217M 1.36B 520M 5.57B 527M 516M 20.49B | 162M 140M 132M 120M 222M 13.99B 250M 1.56B 598M 6.41B 606M 593M 23.56B |
| Net Debt | -69.36M -60.16M -56.67M -51.49M -95.26M -6.01B -107M -671M -257M -2.75B -260M -255M -10.12B | -291M -252M -237M -216M -399M -25.17B -450M -2.81B -1.08B -11.53B -1.09B -1.07B -42.38B |
More financial data
* Estimated data
Employees
1,041
Sector
Pharmaceuticals
Calendar
Jun. 24
- Northland Growth Conference
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 1,047.00 p | +1.95% | 414,902 |
| 25-06-19 | 1,027.00 p | -1.15% | 84,613 |
| 25-06-18 | 1,039.00 p | +0.97% | 156,303 |
| 25-06-17 | 1,029.00 p | -1.06% | 295,805 |
| 25-06-16 | 1,040.00 p | +1.46% | 540,190 |
Delayed Quote London S.E., June 20, 2025 at 11:35 am EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.10USD
Average target price
14.60USD
Spread / Average Target
+3.50%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
